LEXARIA BIOSCIENCE CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
LEXARIA BIOSCIENCE CORP. (LEXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 129.90 thousand shares for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-05-31 was 121.50K shares.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-02-28 was 667.00 shares, a 99.83% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-11-30 was 1.33K shares, a 99.11% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-08-31 was -4.04M shares.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 25.29K shares, a 49.76% decline from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 50.34K shares, a 66.31% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 149.43K shares, a 89.44% decline from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 1.42M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | 121.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | 129.90K shares 10-Q · filed 2026-07-13 | |||
| 2026-02-28 | 8.40K shares 10-Q · filed 2026-04-13 | ||||
| 2025-08-31 | 47.00K shares 10-Q · filed 2026-07-13 | ||||
| 2022-08-31 | 25.29K shares 10-K · filed 2022-11-28 | ||||
| 2021-08-31 | 50.34K shares 10-K · filed 2021-11-29 | ||||
| 2021-02-28 | 667.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | 2.00K shares 10-Q · filed 2021-04-14 | -4.04M shares derived: sum of 3 quarters · filed 2021-11-29 | -398.57K shares derived: sum of 4 quarters · filed 2021-11-29 | |
| 2020-11-30 | 1.33K shares 10-Q · filed 2021-01-14 | -4.04M shares derived: sum of 2 quarters · filed 2021-11-29 | -399.24K shares derived: sum of 3 quarters · filed 2021-11-29 | 1.33K shares derived: sum of 4 quarters · filed 2021-11-29 | |
| 2020-08-31 | -4.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | -400.57K shares derived: sum of 2 quarters · filed 2021-11-29 | -7.00 shares derived: sum of 3 quarters · filed 2021-11-29 | 149.43K shares 10-K · filed 2021-11-29 | 4.48M shares 10-K · filed 2020-10-15 |
| 2020-05-31 | 3.64M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | 4.04M shares derived: sum of 2 quarters · filed 2020-06-29 | 4.19M shares 10-Q · filed 2020-06-29 | ||
| 2020-02-29 | 400.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | 550.00K shares 10-Q · filed 2020-04-03 | |||
| 2019-11-30 | 149.44K shares 10-Q · filed 2021-01-14 | ||||
| 2019-08-31 | 1.42M shares 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |